1Taujimoto Y, Groce CM. Analysis of the structure,transcripts, and protein products of bcl-2,the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA, 1986;83(14),5214.
2Zheng CY, Peballo P, Skinnider LF. Characteristics of a cell line established from a T cell acute Leukemia by transfection with the be1-2 gene. Acta haematol, 1994;91(4):181.
3Camps L. Sabido O, Sebban C, et al. Expression of BCL-2 proto-oncogene in adult acute Lmyphoblastic.Leukemia, 1996;10(3),434.
4Reed JC. BCL-2 and the regulation of programmed cell death. J Cell Biol, 1994;124(1-2):1.
5Camps L, Rouault JP, Sabido O, et al. High expression of bcl-2 protein in acute myeloid leukemia cell is associated with poor respons to chemotherapy. Blood, 1993;81:3091.
6Ichikawa A, Hotta T, Saito H. Mutations of the p53 gene in B-cell lymphoma. Leuk lymphoma,1993;11(1-2):21.
7Wada H, Asada M, Nakazawa S, et al. Clonal expansion of p53 mutant cells in leukemia progression in vitro. Leukemia, 1994;8(1):53.
8Trecca D, Longo L, Biondi A, et al. Analysis of p53 gene mutations in acute myeloid leukemial. Am J Hematel, 1994;46(4):304.
9Even GI, Wyllie AH, Gilhert CS, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 1992;69:119.
10Lotem J, Sachs L. Regulation by he1-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and defective myeloid leukemia cells.Cell Growth Differ, 1993;4(1): 41.
